MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance the security of supply, accessibility and affordability of medicines.
-
Promoting innovation and access to affordable medicinal products
-
Specific rules for novel medicines such as orphan drugs and antimicrobials
-
Medicines to become more environmentally sustainable
[Press release European Parliament]
